Jason Patrick Meyenburg

Chief Commercial Officer, Sucampo Pharmaceuticals.

Companies

Disc Medicine, Inc.Board member Feb 10, 2021 to Jan 5, 2022¹
Disc Medicine, Inc.Chief executive officer Feb 10, 2021 to Jan 5, 2022¹
Disc Medicine, Inc.President Feb 10, 2021 to May 18, 2021¹
Sucampo PharmaceuticalsChief Commercial Officer Jun 12, 2017 to Feb 13, 2018²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDisc Medicine, Inc., Board member
2
SEC EDGARSucampo Pharmaceuticals, Chief Commercial Officer